Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer

Clinical trial NCT03480750 · COMPLETED

Trial details

NCT number: NCT03480750
Sponsor: National Cheng-Kung University Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasms Malignant (Excl Germ Cell)Peritoneal Carcinoma Fallopian Tube Cancer

Start date: 2012-09-01
Primary completion: 2015-10-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.